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Background: Electrospun nanofibers have been widely used as substrata for mammalian cell culture owing to their
structural similarity to natural extracellular matrices. Structurally consistent electrospun nanofibers can be produced
with synthetic polymers but require chemical modification to graft cell-adhesive molecules to make the nanofibers
functional. Development of a facile method of grafting functional molecules on the nanofibers will contribute to
the production of diverse cell type-specific nanofiber substrata.
Results: Small molecules, peptides, and functionalized gold nanoparticles were successfully incorporated with
polymethylglutarimide (PMGI) nanofibers through electrospinning. The PMGI nanofibers functionalized by the
grafted AuNPs, which were labeled with cell-adhesive peptides, enhanced HeLa cell attachment and potentiated
cardiomyocyte differentiation of human pluripotent stem cells.
Conclusions: PMGI nanofibers can be functionalized simply by co-electrospinning with the grafting materials. In
addition, grafting functionalized AuNPs enable high-density localization of the cell-adhesive peptides on the
nanofiber. The results of the present study suggest that more cell type-specific synthetic substrata can be fabricated
with molecule-doped nanofibers, in which diverse functional molecules are grafted alone or in combination with
other molecules at different concentrations.
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Although the invention of electrospinning was disclosed
in the 1930s, electrospinning-related studies have expo-
nentially increased in the last few decades owing to the
demands of nanofibrous structures for diverse applica-
tions [1]. In particular, electrospun nanofibers became
popular in tissue engineering as a substratum because of
their structural similarity with collagen fibers in natural
extracelluar matrices [2,3], which are composed of
submicrometer-sized collagen fibers [4], proteoglycans,
and basal membranes [5]. Many biocompatible natural
polymers, synthetic polymers, or their copolymers have* Correspondence: dongju@icems.kyoto-u.ac.jp
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reproduction in any medium, provided the orbeen successfully used to produce electrospun nanofibers
for mammalian cell culture. The components of natural
polymers are usually structural proteins identified in
extracellular matrix and their derivatives, such as colla-
gen, laminin, and gelatin, whereas poly-E-caprolactone,
poly-L-lactic acid, and poly-D,L-lactic-co-glycolic acid
are synthetic polymers commonly used to produce bio-
compatible electrospun nanofibers [6–10]. The natural
polymers have strong affinities to mammalian cells, but
they have structural inconsistency in wet conditions and
large variations depending on their origin, subtype, and
concentration. Conversely, synthetic polymers produce
structurally consistent nanofibers that lack affinity for
mammalian cells. Thus, achieving the affinity of the
natural polymer and the structural consistency of the
synthetic polymer is desired to produce functionally
strong and structurally consistent nanofibers [11,12].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mimic the affinity of full-length proteins has enabled
high-density localization of the cell affinity function on
the synthetic nanofibers [13,14]. Among the developed
peptides, a peptide composed of 3 amino acids,
arginine-glycine-aspartic acid (RGD), might be the most
widely used grafting material to improve cell affinity for
the synthetic substrata [15–17]. The tripeptide RGD se-
quence is commonly identified among proteins that consti-
tute an extracellular matrix, such as laminin, fibronectin,
and vitronectin, to which integrin receptors bind [18]. Des-
pite its short sequence, the RGD peptide has been known
to mimic the affinity of full-length proteins for integrin
receptors [19]. Moreover, cyclic analogues of the RGD
peptide that have higher affinity for mammalian cells
than their linear counterpart have been developed
[20,21]. Besides the RGD peptide, heparin-binding pep-
tides (HBP) that bind to the anionic heparin polysacchar-
ide, which is a component of extracellular matrix, have
been demonstrated to potentiate adhesion, locomotion,
and growth of mammalian cells, including human pluri-
potent stem cells (PSCs) [22,23]. Coadministration of the
2 peptides, the RGD peptide and HBP, on the synthetic
substratum facilitated long-term culture of human PSCs
[23].
PSCs attract a lot of attention for their potential to
supply any kind of somatic cells in the body. In addition
to embryonic stem cells (ESCs), which are mainly pro-
duced from a preimplantation embryo [24–26], the gen-
eration of induced PSCs (iPSCs) [27,28] has gained even
more attention because iPSCs could be generated from
somatic cells. In particular, patient-derived iPSCs have
great potential for cell therapy and development of
patient-specific diagnostics and drugs. Using human
PSCs to differentiate cardiomyocytes is a good model to
explore such potential of PSCs because cardiomyocytes
can be used for cell transplantation, screening small
molecules that modulate contractility of the heart, and
evaluating efficacy of drugs for heart diseases. To ex-
ploit the full potential of cardiomyocytes, it is necessary
to develop an optimized substratum that potentiates
generation of contractile cardiomyocyte colonies. Con-
ventionally, a gelatin-coated plate has been used, but re-
cent findings indicate that laminins better potentiate
cardiomyocyte differentiation [29,30], which is consist-
ent with the high expression of laminins in mammalian
heart [31]. Laminin is a class of glycoproteins composed
of α, β, and γ chains, from which 15 different laminins
are produced in human tissues [32]. Among the lami-
nins, laminin-511 (composed of α5, β1, and γ1 chains)
and laminin-211 (composed of α2, β1, and γ1 chains)
have proved to be natural protein substrata that facili-
tated the maintenance of human and mouse PSCs for a
longer period in vitro [33,34].Herein, we examined the potentiating activity of a
functionalized nanofiber substratum for cardiomyocyte
differentiation in comparison with that of laminin-211.
The PMGI nanofiber was selected to be functionalized
through electrospinning owing to its proven rigidity that
enables incorporation of small fluorescent molecules
through co-electrospinning [35], similar to the incorpor-
ation of fluorescent proteins in polyurethane nanofibers
[36]. It is intriguing that the small fluorescent molecules
and proteins maintained their fluorescence in the nano-
fibers even though high voltage was applied during the
electrospinning processes, suggesting that adhesive
peptides can be grafted onto nanofibers through co-
electrospinning and still maintain their adhesive func-
tion. We confirmed this hypothesis by potentiating
cardiomyocyte differentiation of human PSCs with the
adhesive peptide-doped nanofiber substratum.
Methods
Electrospinning and fabrication of nanofiber substrata
Electrospinning was processed with 13 % (w/v) PMGI
polymer solution (Microchem, Newton, MA) as described
previously [35]. Briefly, the concentrated solutions of func-
tional molecules were added to the PMGI solution up to
10 % (v/v) and mixed completely: concentrated stock
solutions were 10 mM fluorescent molecules such as
fluorescein and porphine dissolved in ethanol, 1 mM
fluorescent peptides dissolved in dimethylsulfoxide
(DMSO), and 10.7 nM peptide-labeled AuNPs dissolved
in water. The mixed solution was loaded into a syringe
equipped with a 21 one-fourth-gauge blunt-ended steel
needle (Nipro, Osaka, Japan). To produce nanofibers,
8 kV was applied between the needle and a grounded
collector, which was a silicon wafer covered by
aluminum foil, separated 10 cm apart, while the PMGI
solution was released continuously out of the syringe at
a speed of 0.8 μL/min via a syringe pump. The dia-
meters of the collected nanofibers ranged from 300 to
500 nm. Synthetic nanofiber substrata were fabricated
by repeated pipeting of the collected nanofibers, which
were fully soaked in autoclaved Milli-Q water (Milli-
pore, Billerica, MA), against the surface of the polystyr-
ene dishes. Approximately, nanofibers produced with 4
μL of PMGI solution were used to coat a 35 mm dish.
The unbound nanofibers were washed out with auto-
claved Milli-Q water. The substratum was sterilized
under UV light for 4 h before use.
Testing the release of fluorescent molecules
Each fluorescent molecule, the sodium salt of fluorescein
(fluorescein) and the 5,10,15,20-Tetra(4-pyridyl)-21H,
23H-porphine (porphine, Sigma-Aldrich, St. Louis, MO),
was dissolved in DMSO at a 10-mM concentration and
added to the 13 % PMGI solution at a 10 % (v/v) ratio.
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construct nanofiber substrata using 10-cm polystyrene
dishes. Each substratum was incubated at 37°C in 10-mL
phosphate-buffered saline (PBS). Every 5 d, the residual
fluorescence intensities of the nanofiber substrata were
measured using a fluorescent microscope (IX71; Olym-
pus, Tokyo, Japan) and the accompanying MetaMorph
image analysis software (Molecular Devices, Sunnyvale,
CA). The size of the measured area, exposure time, and
threshold were preset for the equal measurement of the
fluorescence intensities of 5 different areas in each sub-
stratum. For the peptide-releasing test, 3 peptides were
custom synthesized (Invitrogen, Tokyo, Japan): a hydro-
phobic peptide composed of 6 leucines, a negatively
charged peptide composed of 6 glutamic acids, and a
positively charged peptide composed of 6 lysines. To
monitor their release, a lysine labeled with fluorescein
isothiocyanate (FITC) was added to each of the peptides.
The FITC intensities in the nanofiber substrata were
measured as described for the small fluorescent mole-
cules, with which the amounts of the residual peptides in
the nanofiber substrata were quantified.Transmission electron microscopy and fast Fourier
transform analysis
Solutions of 20-nM AuNP were used to dope the nanofi-
bers through electrospinning. The AuNP-doped nanofi-
bers were fully soaked in Milli-Q water and fragmented
by pipeting. For transmission electron microscopy
(TEM) observation, microdroplets of the fragmented
nanofibers or the AuNPs were deposited and dried on a
plastic holey film covering a copper grid. TEM was done
using a JEM-2200FS (JEOL Ltd., Tokyo, Japan), operat-
ing at 200 kV. The fast Fourier transform (FFT) analysis
was done with the DigitalMicrograph software package
(Gatan Inc., Pleasanton, CA).Scanning electron microscopy
Mouse R1 ESCs were spread over unfixed PMGI nanofi-
ber mesh and cultured for 1 week under growth medium,
which was composed of DMEM-F12 supplemented with
15 % fetal bovine serum, 0.1 mM 2-mercaptoethanol,
non-essential amino acids, and 1,000 U/ml mouse
leukemia inhibitory factor (LIF; ESGRO) from Millipore
(Billerica, MA). The cells were fixed using 1 % glutaralde-
hyde solution in PBS for 1 h, and then soaked in 100 %
t-butyl alcohol for 1 h. After washing with PBS, the cells
were dried at 4 °C for 30 min. Then, the cells were cov-
ered with a 5-nm-thick gold layer through a sputtering at
200A for 15 sec. Samples were observed with a micro-
scope (JCM-5000; JEOL Ltd., Tokyo, Japan). Using the
same method, plain PMGI nanofibers were prepared for
structural analysis with the SEM microscope.AuNP conjugation with peptides
The unconjugated AuNPs (15 nm; Ted Pella, Redding,
CA) were labeled with functional peptides using a 2-step
method. First, a 1-mM mixture of 16-mercapto-
hexadecanoic acid (MHDA; Sigma-Aldrich, MO) and
the polyethylene glycol (PEG)-based molecule, which
was dissolved in ethanol at a 1:3 ratio (MHDA/PEG),
was added to a basic AuNP solution (pH 11, NaOH) and
stirred for 24 h. In most cases, the mole fraction of the
thiols in the solution was similar to the mole fraction of
the thiols bound to the nanoparticles. The solution was
then filtered 3 times with a 10,000-MWCO filter (Milli-
pore, Billerica, MA) by adding Milli-Q water at each
step. The second step involved linking the peptides to
the AuNPs via 1-ethyl-3-(3-dimethylaminopropyl)carbo-
diimide (EDC; Sigma-Aldrich, MO) and N-hydroxysucci-
nimide (NHS; Acros Organics, Geel, Belgium). To the
AuNP solution being stirred at room temperature, we
added 0.3-mM EDC and 0.75-mM NHS, stirred the
solution for 45 min to activate the carboxyl group,
and then filtered the solution 3 times with 25-mM
2-(N-morpholino)ethanesulfonic acid (MES) buffer. A so-
lution containing a 10-M excess of a mixture of cRGD
peptide (Peptide International, Louisville, KY) and/or
heparin-binding peptide I (BioVision, Milpitas, CA) was
added dropwise to the AuNP solution, which was pre-
adjusted to pH 7.5 with 100-mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) buffer, and
stirred for 2 h. The AuNP solution was filtered 3 times
using a 10,000-MWCO filter to remove the unreacted
molecules and finally reconstituted with Milli-Q water.
Each step of the labeling was confirmed by measuring the
size of the AuNPs using a Zetasizer (Nano-ZS90; Malvern
Instruments Ltd., Malvern, UK).
Contact angle measurement
Nanofiber meshes (1-mm thickness) were laid on a solid
surface on which a water drop was placed. Static contact
angles of the water drops were measured using the ses-
sile drop method on a homemade contact angle instru-
ment and the Low Bond Axisymmetric Drop Shape
Analysis plugin [37] for ImageJ 1.440 software.
HeLa cell adhesion
The nanofiber substrata were constructed with the
PMGI nanofibers containing plain AuNPs, FLAG and
PEG-labeled AuNPs, or cRGD and PEG-labeled AuNPs.
Over the nanofiber substrata, the same number of HeLa
cells (500 cells/cm2) were seeded and incubated at 37°C
in the presence of 5 % CO2 for 6 h. HeLa cell attach-
ment was monitored using a microscope, and the bound
cells were quantified by counting the detached cells after
trypsinization from the 3 dishes of each nanofiber
substratum.
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A human ESC line (KhES-3) and a human iPSC line
(IMR 90-1) were maintained on mitomycin C-treated
mouse embryonic fibroblasts (MEFs) with primate ESC
culture medium (ReproCELL, Yokohama, Japan) con-
taining 5 ng/mL basic fibroblast growth factor (Wako,
Osaka, Japan). The human ESC line was used in con-
formity with the guidelines for derivation and use of
human embryonic stem cells of the Ministry of Educa-
tion, Culture, Sports, Science, and Technology (MEXT)
of Japan. Cardiac differentiation was carried out as
described in a previous study [38], with minor modifica-
tions. Briefly, human PSCs were cultured in suspension
for 24 h in ultra-low-attachment dishes (Corning, Low-
ell, MA) to form aggregates and then transferred onto
3.5-cm polystyrene dishes coated with the nanofibers or
20-μg/mL human recombinant laminin-211 (BioLamina,
Stockholm, Sweden). The generation of cardiac colonies
was enhanced by adding WNT signaling inhibitors,
which were identified by library screening (Minami
et al., in preparation), for days 3–9 of cardiac differenti-
ation. Beating cardiac colonies were counted on day 10;
cell clumps showing synchronized beating were regarded
as a single colony, irrespective of their size.
Results
Release of the fluorescent molecules
Generally, molecule-doped nanofibers have been devel-
oped for controlled release of the doped molecules [39–
41]. In contrast to this, nanofibers used as a substratum
should retain the doped molecules. Because PMGI nano-
fiber was able to maintain its structural integrity after
being used as a substratum of mouse ESCs (Additional
file 1: Figure S1), we examined holding property of
PMGI nanofibers toward doped molecules with different
chemical properties, which were integrated into the
nanofiber through electrospinning, as depicted in the
diagram in Figure 1. To this end, 2 small fluorescent
molecules, a fluorescein and a porphine, were selected
based on their different hydrophobicities: the fluorescein
is hydrophilic, whereas the porphine is hydrophobicFigure 1 Construction of molecule-doped nanofibers through
electrospinning. Small molecules, peptides, or gold nanoparticles
were premixed in the 13 % PMGI solution with which electrospun
nanofibers were produced. The premixed molecules, indicated with
red dots, were integrated onto the nanofiber during the
electrospinning process.(Figure 2A). Similarly, 3 peptides were synthesized to
have different charges: (1) a peptide composed of nega-
tively charged amino acids, (2) a peptide composed of
positively charged amino acids, and (3) a peptide com-
posed of uncharged hydrophobic amino acids. These
peptides contained an additional FITC-labeled lysine
peptide at their carboxy terminus for monitoring. The
fluorescent molecule-doped nanofibers were soaked inFigure 2 Release of small fluorescent molecules and peptides
from the PMGI nanofibers. The 2 fluorescent small molecules,
fluorescein and porphine (a), and the 3 peptides (6X Lys, 6X Glu, and
6X Leu) containing FITC-labeled lysine at each carboxy terminus
were used to dope the nanofibers with which polystyrene dishes
were coated. The dishes were incubated at 37°C in PBS. The residual
amounts of the fluorescent small molecules (b) or fluorescent
peptides (c) in the nanofibers were quantified using a fluorescent
microscope. The fluorescence intensity of each nanofiber substratum
on the first day was defined as 100 %. A.U. indicates arbitrary unit.
Error bars: SEM, n = 5.
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repeated pipeting, by which approximately 40 % of the
dish surface was covered with the nanofibers (Additional
file 2: Figure S2). The coated dishes were incubated at
37°C in a PBS solution for 20 d. During the incubation
period, the fluorescence intensity of each nanofiber sub-
stratum was measured every 5 day and plotted against
its own initial intensity as a percentage. A gradual de-
crease in fluorescence intensity, which indicates release
of the fluorescent molecules, was observed in the nanofi-
ber substrata containing fluorescein or charged peptides
composed of lysines or glutamic acids, whereas such a
decrease was minimal in the nanofiber substratum con-
taining the porphine or leucine peptide (Figure 2B,C).
However, the gradual decreases disappeared after 15 d,
resulting in higher than 90 % of the initial fluorescence
remaining up to 20 d, regardless of the chemical prop-
erty of the doped molecules. These results indicate that
the doped molecules remained in the PMGI nanofibers
irrespective of their chemical properties.
Doping of gold nanoparticles
Synthetic substrata for human PSCs is required to have a
large amount of cell-adhesive molecules because of the
low adhesion of human PSCs. To achieve this, we used aFigure 3 PEG-labeled AuNPs localized on the surface of the nanofibe
through electrospinning (a). To enhance stability and surface localization
1-nm-thick layer formed (distance between the 2 red lines) on the surfa
surface of the nanofiber through electrospinning (d, e). The particles sho
The red arrows indicate AuNPs. Scale bars in each figure: A = 50 nm, C =gold nanoparticle (AuNP) because its large surface area
enables high-density labeling of functional molecules
with low cytotoxicity [42,43]. In addition, AuNPs have
been successfully encapsulated into nanofibers through
electrospinning [44,45]. The 15-nm unconjugated
AuNPs, which were stabilized in citrate buffer, were able
to dope the PMGI nanofibers through electrospinning,
but they rarely localized on the surface at 1 nM concen-
tration (Figure 3A). We hypothesized that aggregation of
the AuNPs might be the reason. To prevent aggregation,
the AuNPs were labeled with a PEG-based molecule
(PEG), as depicted in the diagram (Figure 3B), and a
1-nm thick layer was formed outside the AuNPs after
PEG-labeling (Figure 3C). Higher resolution TEM images
supported the formation of PEG layers (Additional file 3:
Figure S3). As expected, the surface localization of PEG-
labeled AuNPs increased significantly (Figure 3D). A
high-resolution TEM image of the nanofiber ensured
that the large surface area of the nanofiber was covered
with PEG-labeled AuNPs (Figure 3E). The particles on
the nanofiber surface were confirmed as Au via an FFT
analysis (Figure 3F). Alternatively, increase of the AuNP
concentration (ﬃ 50 nM) enabled surface localization of
AuNPs (Additional file 4: Figure S4), but it inhibited at-
tachment of PMGI nanofiber to the dish surface (datar. A few plain AuNPs localized sporadically on the nanofiber surface
, AuNPs were labeled with the PEG-based molecules (b), by which a
ce of the AuNPs (c). The PEG-labeled AuNPs mainly localized on the
wn on the nanofibers were confirmed as gold via FFT analysis (f).
10 nm, D= 100 nm, and E = 5 nm.
Figure 4 An anti-FLAG antibody recognized the FLAG peptide
in the nanofibers. Each of the nanofiber substratum containing
PEG-AuNPs, FLAG-AuNPs, or AuNPs co-labeled with PEG and FLAG
was incubated with an Alexa 555-conjugated anti-FLAG antibody.
Fluorescence intensities inside the dashed circles were quantified
using a fluorescence microscope at ×40 resolution (a). The mean
fluorescence intensity of each nanofiber substratum was calculated
by measuring the fluorescence intensities of 5 different areas of
each nanofiber substratum (b). The fluorescence intensities indicate
the amount of the recognized FLAG peptides in the nanofibers by
the fluorescence-labeled anti-FLAG antibody. Error bars: SEM, n = 5.
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AuNPs also changed the hydrophobicity of the nanofi-
bers: the contact angle of the water drop placed on the
nanofibers containing the PEG-labeled AuNPs decreased
owing to the increased absorption of water (Additional
file 5: Figure S5). Thus, AuNPs can dope PMGI nanofi-
bers through electrospinning and their localization on
the surface can be controlled.
Molecular recognition of a doped peptide
Next, we investigated whether a peptide can be localized
on the nanofiber surface using the PEG-labeled AuNP
and electrospinning. The surface localization of the pep-
tide was confirmed via molecular recognition by an anti-
body. To this end, AuNPs were labeled with the 3X
FLAG peptide, which is widely used as a tagging se-
quence, through a MHDA linker, with or without PEG
as depicted in the diagram (Additional file 6: Figure S6).
Labeling of the linker and peptide was confirmed by
measuring the size of the AuNPs using a Zetasizer (Add-
itional file 7: Figure S7). After doping the FLAG-labeled
AuNPs, the nanofibers were incubated with an anti-
FLAG antibody labeled with Alexa 555. The molecular
recognition of the FLAG peptides by the antibody was
quantified by measuring fluorescence intensities of the
nanofiber substrata. The AuNP labeled only with FLAG
peptide failed to be recognized by the antibody, which
was consistent with the rare surface localization on plain
AuNPs, whereas a much higher amount of the FLAG
peptide labeled the AuNPs was recognized when PEG
was present (Figure 4A). The mean fluorescence inten-
sity of 5 different areas in each nanofiber substratum
showed surface localization of the FLAG peptide as
recognized by the anti-FLAG antibody (Figure 4B).
Doping with cRGD peptide improved affinity of the
nanofiber
Based on the FLAG peptide doping, a cRGD peptide
was grafted into the PMGI nanofiber through electro-
spinning, with which we constructed a nanofiber sub-
stratum to examine whether the cRGD-doped nanofiber
might have enhanced affinity for binding integrins
expressed on the attached cells. Synthetic substrata com-
posed of nanofibers containing PEG-AuNPs or FLAG-
labeled AuNPs were fabricated as controls to monitor
the effect of PEG or the non-adhesive peptide (FLAG)
on cell adhesion, respectively. HeLa cells (500 cells/cm2)
were spread over each substratum and incubated for 6 h.
The cells grown on the nanofiber substratum containing
cRGD revealed enhanced attachment and spreading, as
determined by the formation of its unique shape indi-
cated by the red arrows, whereas there was no cell or
only a limited number of cells with such attachment and
spreading on the substrata containing FLAG-AuNPs orPEG-AuNPs, respectively (Figure 5A). The strongly
attached cells were collected from 3 dishes of each nano-
fiber substratum via trypsinization. The mean number of
collected cells from the cRGD-containing substrata was
significantly higher than that from the other 2 substrata
(Figure 5B), which indicates that the adhesive function
of cRGD can be grafted upon nanofibers through
electrospinning.
A functionalized nanofiber substratum for cardiomyocyte
differentiation
Similar to the cRGD-doped nanofiber substratum, the
nanofibers containing AuNPs labeled with 2 adhesive pep-
tides, a cRGD peptide and a HBP, were used to fabricate a
substratum for cardiomyocyte differentiation of human
PSCs. The functionality of the nanofiber substratum was
compared with that of laminin-211, a proven substratum
for human PSCs. A nanofiber substratum containing
PEG-AuNPs was also used to evaluate the structural func-
tionality of the nanofiber to cardiomyocyte differentiation.
Human ESCs (khES1) and iPSCs (201B7), which were
maintained over MEFs in the growth medium, became
embryoid bodies (EBs) via suspension culture. The same
number of the EBs were spread over 3 dishes of each sub-
stratum and then induced to differentiate into cardiomyo-
cytes using the differentiation medium (Figure 6A). After
10 d, spontaneous contractile colonies began to appear.
The effect of each substratum on cardiomyocyte
Figure 5 Enhanced adhesion of HeLa cells to the cRGD-doped
nanofiber substratum. AuNPs labeled with cRGD and PEG were
used to dope the PMGI nanofibers through electrospinning, with
which a synthetic substratum was fabricated. The same number of
HeLa cells were seeded and incubated for 6 h over the cRGD-doped
nanofiber substrata and other nanofiber substrata containing plain
AuNPs or FLAG-labeled AuNPs. The red arrows indicate attached and
spread HeLa cells (a). After washing the cells with PBS, the
remaining cells were collected from the 3 dishes of each substratum
via trypsinization for quantification (b). Scale bar: 50 μm. Error bars:
SEM, n = 3.
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of beating colonies developed in each substratum. A beat-
ing colony was defined as a clump of cells showing syn-
chronized contractility, irrespective of its size (Figure 6B,
outlined). The mean number of beating colonies was sta-
tistically higher in the nanofiber substratum containing
cRGD and HBP than in the laminin-211 substratum or in
the nanofiber substratum containing PEG-AuNP (P
< 0.01). Unexpectedly, the mean colony number from the
nanofiber substrata containing PEG-AuNPs was compar-
able with that from the laminin-coated substrata
(Figure 6C). Thus, the PMGI nanofiber substratum func-
tionalized with the adhesive peptides through electrospin-
ning enhanced cardiomyocyte differentiation of human
PSCs even better than did laminin-211.Discussion
Nanofibers are proven substrata for culturing somatic
cells, but their application to PSCs has recently been
investigated [46]. Herein, we introduced an application
of the nanofiber substratum to cardiomyocyte differen-
tiation of human PSCs. Usually, surface modifications,
such as amines [21], carboxylic acids [47], and alka-
nethiols [23], are required for grafting cell adhesive
molecules on synthetic substrata. However, our results
indicate that co-electrospinning can also be used as a
method to graft cell adhesive peptides when PMGI
nanofibers and PEG-labeled AuNPs are used. The rigidstructure of the PMGI nanofibers enabled incorporation
of the AuNPs, whereas the PEG-labeled AuNPs deliv-
ered a large amount of the peptides onto the nanofiber
surface. Such high-density localization of the functional
peptides on the nanofibers fulfills the biophysical and
biochemical environmental cues required for PSC cul-
ture [23,48]. Embedding of AuNPs into nanofibers has
been introduced to add mechanical functions to the
nanofibers: AuNPs were incorporated in silica nanofi-
bers and in TiO2 nanofibers through electrospinning
for the wavelength-dependent photoelectric response
and for enhancing lithium-ion diffusion and charge
transfer, respectively [44,45]. Unlike the previous
reports, we used AuNPs to add biological functions to
the nanofibers. The proof of concept of such “AuNP
doping” through electrospinning was confirmed by rec-
ognition of the FLAG and cRGD peptides, which were
localized on the nanofiber surface via the AuNP, by the
anti-FLAG antibody and RGD receptors expressed on
HeLa cells, respectively. HeLa cells are known to follow
3 events during cell adhesion: initial attachment,
spreading, and elaborate interaction with the substra-
tum using their 3 types of RGD receptors [49]. There-
fore, the strong attachment and spreading of HeLa cells
on the cRGD-doped nanofiber substratum indirectly
indicates recognition of cRGD by the RGD receptors
on the HeLa cells. Similarly, a nanofiber substratum
functionalized with cRGD and HBP enhanced cardio-
myocyte differentiation of the human PSCs. These 2
peptides have been known to potentiate self-renewal of
human PSCs [23], and we found that the combination
of these 2 peptides also potentiated cardiomyocyte dif-
ferentiation better than did laminin-211 (Figure 6).
Nevertheless, these 2 peptides may not be the best
functional materials for potentiating cardiomyocyte dif-
ferentiation, considering the increase of cell clumps that
didn't beat were observed simultaneously in the
peptide-doped nanofiber substratum (data not shown).
These 2 peptides would be rather conventional sub-
strata for diverse cell types combined with specific cul-
ture medium. Screening of peptides and small
molecules that relatively specific to cardiomyocyte dif-
ferentiation will be conducted using this nanofiber
method. It is interesting that nanofibers containing
PEG-AuNPs potentiated cadiomyocyte differentiation as
much as the laminin-211 did, which was an unexpected
result because cardiomyocyte differentiation of human
PSCs was erratic and poor over the plain culture dishes
that had neither biophysical nor biochemical environ-
mental cues from the extracellular matrix; we observed
significant decrease of beating colony formation with
high batch-to-batch variation when plain dishes were
used instead of laminin-211 coated dishes (data not
shown). We infer that it might be caused by preference
Figure 6 The functionalized nanofiber substratum potentiates cardiomyocyte differentiation. Human PSCs were cultured over the MEF. To
induce cardiomyocyte differentiation, EBs were formed by culturing the PSCs over ultra-low-attachment culture dishes. The same number of EBs
were spread and differentiated for 10 d over each of the substratum as depicted in the diagram (a). Laminin-211 indicates laminin-211-coated
dishes, PEG-AuNP indicates nanofiber substrata containing the PEG-AuNPs, and PEG-AuNP-HBP + cRGD indicates nanofiber substrata containing
PEG-AuNPs functionalized with HBP and cRGD. After 10 d of differentiation, cell clumps showing spontaneous contractility appeared. A single
cardiomyocyte colony was defined as a cell clump showing synchronized beating (black outlined), irrespective of its size (b). Cardiomyocyte
colonies generated in 3 dishes of each substratum were counted for quantification (c). Scale bars: 500 μm. Error bars: SEM, n = 3. The asterisks
indicate statistical significance (P< 0.01) calculated using the Student t test. The results shown represent 3 independent experiments. PSC:
pluripotent stem cell, MEF: mouse embryonic fibroblast, EB: embryoid body, Growth: growth medium, and Differentiation: differentiation medium.
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the absence of the biochemical cues as reported [50].
The method described here has attractive points in
terms of cost, convenience, and applicability: the PMGI
nanofiber is cheap, and functionalization is achieved
through simple co-electrospinning and can be applied to
examine concentration-dependent effects and combina-
torial effects of different functional molecules to the
cells. The produced functionalized nanofibers can be ap-
plied to lithographic patterning of the nanofibers as
described [35] for more precisely controlled differenti-
ation of PSCs and also used to develop a cell type-
specific substratum for the cells having uniquecharacteristics, such as motor neurons and hepatocytes,
which are difficult to maintain or obtain in vitro using a
conventional substratum.
Conclusions
Our findings indicate that PMGI nanofibers can inte-
grate small molecules, peptides, and functionalized
AuNPs through electrospinning. Using this technique,
we were able to fabricate synthetic nanofiber substrata
that enhanced HeLa cell adhesion or potentiated cardio-
myocyte differentiation of human PSCs.
We believe that these results would serve as a founda-
tion to fabricate diverse cell type-specific substrata.
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Additional file 1: Figure S1. SEM images of PMGI nanofibers.
Nanofibers maintained their structure. (A) Structure of newly produced
PMGI nanofibers. (B) A mouse ESC colony cultured over PMGI nanofibers
for 1 week was observed.
Additional file 2: Figure S2. The surface of a polystyrene dish can
be coated with PMGI nanofibers by pipeting. Rhodamine 6B (10-μM
final concentration) was premixed in 13 % PMGI solution and then
incorporated into the nanofibers via electrospinning. A polystyrene dish
(10 cm) was coated with the Rhodamine-doped nanofibers by pipeting
the nanofibers repeatedly against the surface. The fluorescence image
indicates that Rhodamine remains in the nanofiber under PBS, which was
monitored with a fluorescence confocal microscope. Scale bars: 50 μm.
Additional file 3: Figure S3. TEM images of PEG-labeled AuNPs.
High resolution TEM images showed formation of PEG layer on the
surface of AuNPs. Red arrows indicate the PEG layer. Scale bars: A = 10 nm
and B= 5 nm.
Additional file 4: Figure S4. TEM images of PMGI nanofiber containing
higher number of AuNPs. Plain AuNPs (ﬃ 50 nM) were integrated into
PMGI nanofiber through co-electrospinning with which a TEM image was
taken. Scale bars: A = 0.5 μm and B = 100 nm.
Additional file 5: Figure S5. Contact angle measurements. The high-
density PMGI nanofibers were fixed on a solid polydimethylsiloxane
(PDMS) gel using adhesive silicon on which a drop of Mili-Q water was
placed on the nanofiber meshes to measure its contact angle. Surface
localization of the PEG-labeled AuNP made the nanofiber substratum
hydrophilic, resulting in a decreased contact angle of the water drop. Au
and Au-PEG indicate plain gold nanoparticle and polyethylene glycol-
labeled gold nanoparticle, respectively.
Additional file 6: Figure S6. Labeling process of a AuNP with
functional peptides. The surface of a 15-nm AuNP was labeled with 75
% PEG and 25 % MHDA using equal amounts of cRGD and HBP covalently
conjugated through EDC/NHS coupling. EDC: 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide, NHS: N-hydroxysuccinimide, and MHDA: 16-
mercaptohexadecanoic acid.
Additional file 7: Figure S7. Size measurement of a functionalized AuNP.
The size of an AuNP labeled with the 3X FLAG peptide
(NH2-MDYKDHDGDYKDHDIDYKDDDDK-OH) through MHDA was measured.
The surface of a 15-nm AuNP (A) was covered with 75 % PEG and 25 % MHDA
(B), and the FLAG peptide was conjugated at the MHDA (C). The growing size of
the AuNP after each labeling process was measured using a Zetasizer. The actual
size of the functionalized FLAG-AuNP almost exactly matched the predicted size,
which was calculated based on the length of the linker and 3X FLAG peptide.
The results represent 3 independent measurements.
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